The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

About Diabetic Retinopathy (DR) Diabetic retinopathy (DR) affects almost 10 million people in the U.S. and more than 100 million people globally, accounting for almost 5% of all cases of blindness.

Palatin Unveils Promising Preclinical Data For Diabetic Retinopathy Treatments At ARVO 2025 May 09, 2025 — 05:42 pm EDT Written by RTTNews.com for RTTNews -> ...

New research from Johns Hopkins Medicine suggests that low blood sugar may contribute to diabetic retinopathy and vision loss. The study identifies how hypoglycemia triggers damaging effects in ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the condition.

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; experimental drug may help treat condition Date: May 6, 2025 Source: Johns Hopkins Medicine Summary: Scientists ...

This breakdown in diabetic retinopathy contributes to irreversible damage to the retina and vision loss. The team investigated further by testing an experimental drug known as 32-134D, which ...

Researchers are planning future studies on HIF, the breakdown of the blood-retinal barrier and 32-134D, and hope to conduct clinical studies of 32-134D in patients with diabetic retinopathy.

What Causes Diabetic Macular Edema? Diabetic macular edema is a complication of diabetic retinopathy.

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

Dr. Amit Gupta, MD, FACS, Ophthalmologist, talks about what to expect after having laser eye treatment for diabetic retinopathy.